Sperm Micro-swim up Technique; Process and Select in the Same Dish: a Sibling-oocyte-split Design
NCT ID: NCT05113225
Last Updated: 2022-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
156 participants
INTERVENTIONAL
2021-10-10
2021-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Oocyte Activation: Revised or Initial AGT Technique, Which is Better?! A Sibling-oocytes-split Design
NCT05113238
Evaluating the Utility of Implementing Microfluids for Sperm Preparation Compared to Conventional Method of Density Gradient Centrifugation in a PGT-A Program: a Sibling Oocyte Study
NCT07093619
Effect of Different Sperm Processing Methods in ICSI Outcome.
NCT03668106
Co-incubation of Oocytes With Sperm: Defining the Optimal Incubation Time
NCT04627545
A New Micro Swim-up Procedure for Sperm Preparation in ICSI Treatment
NCT02672124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The dishes will be prepared with droplets of handling medium for oocytes (droplet volume 10 μL), and an H pattern using PVP will be produced, finally, all the droplets will be overlaid with mineral oil.
Control group : Oocytes will be injected using sperm after processing with DG and will be selected from control PVP microdroplets
Sample group: Sperm will be directly loaded in specific ICSI dishes where is the PVP microdroplets is prepared on "H" Pattern and will be selected from the far point from the deposition point and will be injected into the oocytes from the sample group All injected MII oocytes from both groups will then be cultured, with each group demarcated in separate place in the culture dish then according to the randomisation embryo transfer will be selected from one of both groups then the quality of the embryos will be reported and the pregnancy rate
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DG-ICSI
Oocytes of this arm will be injected using sperm previously processed by DG method and located in the commonly used ICSI dishes with the common PVP microdroplets
Micro-swim up technique
processing and selection of the sperm for ICSI in the same dish
H pattern-ICSI
Oocytes of this arm will be injected using sperm that directly located in a specific H pattern PVP droplets in a commonly used ICSI dishes without pre-processing of the semen
Micro-swim up technique
processing and selection of the sperm for ICSI in the same dish
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Micro-swim up technique
processing and selection of the sperm for ICSI in the same dish
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age: 18 - 40 years
* anti-Müllerian hormone (AMH): \> 1.0 ng/ml
* number of aspirated oocytes:more than or equal 8
* BMI \< 34
Exclusion Criteria
* AMH \< 1.0 ng/mL;
* aspirated oocytes \< 8.
* severe male factor
* Testicular aspirated sperm
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hawaa Fertility Center
OTHER
Royal Fertility Center, Egypt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sahar SA Eissa, PHD
Role: STUDY_DIRECTOR
research team leader
Engy EA Abdallah, MSC
Role: STUDY_CHAIR
investigator & researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Fertility Center
Al Mansurah, Daqahlya, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.